REG - Polar Capital Hldgs - Block listing Interim Review
RNS Number : 7726WPolar Capital Holdings PLC06 August 2018POLAR CAPITAL HOLDINGS PLC
Legal Entity Identifier: 549300OXX7YE1947B825
BLOCK LISTING RETURN - 6 August 2018
Name of applicant:
Polar Capital Holdings plc
Name of scheme:
Equity Incentive Plan
Executive Incentive Plan
SAYE Sharesave Scheme
Period of return:
From:
4 February 2018
To:
3 August 2018
Balance of unallotted securities under scheme(s) from previous return:
Equity Incentive Plan - 552,700
Executive Incentive Plan - 1,000,000
SAYE Sharesave Scheme - 469,388
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Equity Incentive Plan - 2,000,000
Executive Incentive Plan - NIL
SAYE Sharesave Scheme - NIL
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
Equity Incentive Plan - 308,358
Executive Incentive Plan - NIL
SAYE Sharesave Scheme - NIL
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
Equity Incentive Plan - 2,244,342
Executive Incentive Plan - 1,000,000
SAYE Sharesave Scheme - 469,388
Name of contact:
Neil Taylor
Telephone number of contact:
020 7227 2700
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDBLRGMGGRLFDGRZG
Recent news on Polar Capital Holdings
See all newsREG - Polar Capital Hldgs Renalytix PLC - Form 8.3 - Renalytix PLC
AnnouncementREG - Polar Capital Hldgs Renalytix PLC - Form 8.3 - RENALYTIX PLC
AnnouncementREG - Polar Capital Hldgs - Holding(s) in Company
AnnouncementREG - Polar Capital Hldgs Direct Line Ins Grp - Form 8.3 - DIRECT LINE INSURANCE GROUP PLC
AnnouncementREG - Polar Capital Hldgs Renalytix PLC - Form 8.3 - RENALYTIX PLC
Announcement